Cosmax Nbt, Inc. Stock price

Equities

A222040

KR7222040008

Food Processing

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
4,700 KRW +0.43% Intraday chart for Cosmax Nbt, Inc. +2.17% -26.79%
Sales 2024 * 374B 278M Sales 2025 * 398B 296M Capitalization 96.61B 71.78M
Net income 2024 * 15B 11.14M Net income 2025 * 20B 14.86M EV / Sales 2024 * 0.57 x
Net Debt 2024 * 118B 87.45M Net Debt 2025 * 92.5B 68.73M EV / Sales 2025 * 0.47 x
P/E ratio 2024 *
6.29 x
P/E ratio 2025 *
4.64 x
Employees 531
Yield 2024 *
-
Yield 2025 *
-
Free-Float 60.61%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
Cosmax Nbt, Inc.'s Equity Buyback announced on June 27, 2023, has closed with 169,491 shares, representing 0.82% for KRW 1,006.06 million. CI
Cosmax Nbt, Inc. announces an Equity Buyback for 169,491 shares. CI
Cosmax Nbt, Inc. authorizes a Buyback Plan. CI
Cosmax Nbt, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Synbio Tech Inc. and Cosmax Group Signs an Exclusive Cooperation Agreement to Jointly Expand the South Korean Probiotics Market CI
Cosmax Nbt, Inc.(KOSDAQ:A222040) dropped from S&P Global BMI Index CI
Holzapfel Effective Microbes Co., Ltd. announced that it expects to receive KRW 10.90002816 billion in funding from Friend Investment Partners Co., Ltd., Cosmax Nbt, Inc., Amorepacific Corporation, Pyxis Innovations, Inc., GU Equity Partners LLC and another investor CI
Nutribiotech Australia Pty. Ltd. announced that it has received AUD 10 million in funding from Cosmax Nbt, Inc. CI
Cosmax NBT announced that it has received KRW 10.5822 billion in funding from Cosmax Nbt, Inc. CI
NutriBiotech Co., Ltd. cancelled the acquisition of Nutribiotech Australia Pty. Ltd. CI
NutriBiotech Co., Ltd.(KOSDAQ:A222040) added to Russell Global Index CI
NutriBiotech Co., Ltd.(KOSDAQ:A222040) added to S&P Global BMI Index CI
NutriBiotech Co., Ltd. agreed to acquire Nutribiotech Australia Pty. Ltd for KRW 8.6 billion CI
More news
1 day+0.43%
1 week+2.17%
Current month-13.12%
1 month-9.96%
3 months-26.79%
6 months-19.66%
Current year-26.79%
More quotes
1 week
4 370.00
Extreme 4370
4 850.00
1 month
4 210.00
Extreme 4210
5 490.00
Current year
4 210.00
Extreme 4210
7 330.00
1 year
4 120.00
Extreme 4120
7 330.00
3 years
3 795.00
Extreme 3795
12 900.00
5 years
2 720.00
Extreme 2720
16 750.00
10 years
2 720.00
Extreme 2720
41 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 20-12-29
Chief Tech/Sci/R&D Officer 58 12-07-31
Director/Board Member 44 18-05-31
Members of the board TitleAgeSince
Director/Board Member 44 18-05-31
Chief Executive Officer 59 20-12-29
Director/Board Member 69 -
More insiders
Date Price Change Volume
24-03-28 4,700 +0.43% 39,218
24-03-27 4,680 -1.06% 124,912
24-03-26 4,730 -1.05% 61,367
24-03-25 4,780 +5.29% 119,560
24-03-22 4,540 -1.30% 223,447

End-of-day quote Korea S.E., March 27, 2024

More quotes
COSMAX NBT, INC., formerly NUTRIBIOTECH. CO., LTD., is a company mainly engaged in the manufacturing and sale of health functional foods. The Company is engaged in the research and development of functional raw materials and ingredients, the production and sale of health functional foods and health oriented foods.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4,700 KRW
Average target price
7,150 KRW
Spread / Average Target
+52.13%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Cosmax Nbt, Inc. - Korea S.E.